Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: SORRENTO THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-06-01 to 2025-05-31
Current total value of award: $4590862
Description: BAA RESEARCH AREA 004 - "DEVELOPMENT OF IN VITRO FOR BIODEFENSE, ANTIMICROBIAL RESISTANT (AMR) INFECTIONS AND EMERGING INFECTIOUS DISEASES"